UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Cancer epidemiology, biomarkers & prevention, 2017-08, Vol.26 (8), p.1248-1254

2017

Volltextzugriff (PDF)

Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome

PloS one, 2014-06, Vol.9 (6), p.e98229-e98229

2014

Volltextzugriff (PDF)

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Cancer research (Chicago, Ill.), 2017-09, Vol.77 (18), p.4755-4762

2017

Volltextzugriff (PDF)

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

Breast cancer research : BCR, 2009-01, Vol.11 (4), p.R47-R47

2009

Volltextzugriff (PDF)

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

Breast cancer research : BCR, 2006-01, Vol.8 (4), p.R38-R38

2006

Volltextzugriff (PDF)

A DNA methylation-based definition of biologically distinct breast cancer subtypes

Molecular oncology, 2015-03, Vol.9 (3), p.555-568

2015

Volltextzugriff (PDF)

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker

Carcinogenesis (New York), 2013-01, Vol.34 (1), p.102-108

2013

Volltextzugriff (PDF)

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer

Cancer cell, 2010-11, Vol.18 (5), p.499

2010

Volltextzugriff (PDF)

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19), p.5608-5619

2014

Volltextzugriff (PDF)

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genes chromosomes & cancer, 2011-11, Vol.50 (11), p.930-939

2011

Volltextzugriff (PDF)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R95-R95

2011

Volltextzugriff (PDF)

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

JNCI cancer spectrum, 2020-04, Vol.4 (2), p.pkz100-pkz100

2020

Volltextzugriff (PDF)

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

Oncogene, 2003-01, Vol.22 (3), p.445-450

2003

Volltextzugriff (PDF)

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

Cancer letters, 2007-06, Vol.250 (2), p.206-212

2007

Volltextzugriff (PDF)

The Icelandic founder mutation BRCA2 999del5: analysis of expression

Breast cancer research : BCR, 2004-01, Vol.6 (4), p.R284-R290, Article R284

2004

Volltextzugriff (PDF)

Aurora-A amplification associated with BRCA2 mutation in breast tumours

Cancer letters, 2007-04, Vol.248 (1), p.96-102

2007

Volltextzugriff (PDF)

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Cellular oncology : the official journal of the International Society for Cellular Oncology, 2009, Vol.31 (3), p.191-201

2009

Volltextzugriff (PDF)

AURKA and breast cancer in BRCA1/2 mutation carriers

Cancer epidemiology, biomarkers & prevention, 2007-11, Vol.16 (11), p.2517-2517

2007

Volltextzugriff (PDF)

BRCA2 mutation carriers, reproductive factors and breast cancer risk

Breast cancer research : BCR, 2003, Vol.5 (5), p.R121-R128

2003

Volltextzugriff (PDF)

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition

Investigational new drugs, 2012-04, Vol.30 (2), p.425-434

2012

Volltextzugriff (PDF)

Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short-term culture

Genes chromosomes & cancer, 1995-08, Vol.13 (4), p.239-248

1995

Volltextzugriff (PDF)

MYC amplification and TERT expression in breast tumor progression

Cancer genetics and cytogenetics, 2007-07, Vol.176 (2), p.93-99

2007

Volltextzugriff (PDF)

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains

Genes chromosomes & cancer, 1995-09, Vol.14 (1), p.71-75

1995

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBritish Journal Of Cancer

ThemaMedical Sciences

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Telomere Length Is Predictive of Breast Cancer Risk in BRCA2 Mutation Carriers

Systematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome

Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency

Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer

A DNA methylation-based definition of biologically distinct breast cancer subtypes

DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker

Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer

A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition

Cytogenetic polyclonality of breast carcinomas: Association with Clinico-Pathological Characteristics and Outcome

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity

Breast cancer risk associated with AURKA 91T → A polymorphism in relation to BRCA mutations

The Icelandic founder mutation BRCA2 999del5: analysis of expression

Aurora-A amplification associated with BRCA2 mutation in breast tumours

BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

AURKA and breast cancer in BRCA1/2 mutation carriers

BRCA2 mutation carriers, reproductive factors and breast cancer risk

Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition

Cytogenetic studies of breast carcinomas: Different karyotypic profiles detected by direct harvesting and short-term culture

MYC amplification and TERT expression in breast tumor progression

TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc-binding domains

Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study

Aktive Filter

Suchergebnisse filtern